111 related articles for article (PubMed ID: 22253097)
21. Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell cycle regulators.
Yin F; Wakino S; Liu Z; Kim S; Hsueh WA; Collins AR; Van Herle AJ; Law RE
Biochem Biophys Res Commun; 2001 Sep; 286(5):916-22. PubMed ID: 11527386
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of peripheral benzodiazepine receptor ligand-induced apoptosis and cell cycle arrest of esophageal cancer cells by simultaneous inhibition of MAPK/ERK kinase.
Sutter AP; Maaser K; Gerst B; Krahn A; Zeitz M; Scherübl H
Biochem Pharmacol; 2004 May; 67(9):1701-10. PubMed ID: 15081869
[TBL] [Abstract][Full Text] [Related]
23. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
Morris TA; DeLorenzo RJ; Tombes RM
Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994
[TBL] [Abstract][Full Text] [Related]
24. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
25. Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert.
Turbyville TJ; Wijeratne EM; Liu MX; Burns AM; Seliga CJ; Luevano LA; David CL; Faeth SH; Whitesell L; Gunatilaka AA
J Nat Prod; 2006 Feb; 69(2):178-84. PubMed ID: 16499313
[TBL] [Abstract][Full Text] [Related]
26. Antiproliferative effect of natural tetrasulfides in human breast cancer cells is mediated through the inhibition of the cell division cycle 25 phosphatases.
Viry E; Anwar A; Kirsch G; Jacob C; Diederich M; Bagrel D
Int J Oncol; 2011 Apr; 38(4):1103-11. PubMed ID: 21253673
[TBL] [Abstract][Full Text] [Related]
27. 3-Amino-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: a new class of CDK2 inhibitors.
Pevarello P; Fancelli D; Vulpetti A; Amici R; Villa M; Pittalà V; Vianello P; Cameron A; Ciomei M; Mercurio C; Bischoff JR; Roletto F; Varasi M; Brasca MG
Bioorg Med Chem Lett; 2006 Feb; 16(4):1084-90. PubMed ID: 16290148
[TBL] [Abstract][Full Text] [Related]
28. Novel merosesquiterpene exerts a potent antitumor activity against breast cancer cells in vitro and in vivo.
Carrasco E; Álvarez PJ; Melguizo C; Prados J; Álvarez-Manzaneda E; Chahboun R; Messouri I; Vázquez-Vázquez MI; Aránega A; Rodríguez-Serrano F
Eur J Med Chem; 2014 May; 79():1-12. PubMed ID: 24704691
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antitumor activity of novel O-carbamoylmethyloxime derivatives of radicicol.
Ikuina Y; Amishiro N; Miyata M; Narumi H; Ogawa H; Akiyama T; Shiotsu Y; Akinaga S; Murakata C
J Med Chem; 2003 Jun; 46(12):2534-41. PubMed ID: 12773056
[TBL] [Abstract][Full Text] [Related]
30. Structure-based discovery of the first allosteric inhibitors of cyclin-dependent kinase 2.
Rastelli G; Anighoro A; Chripkova M; Carrassa L; Broggini M
Cell Cycle; 2014; 13(14):2296-305. PubMed ID: 24911186
[TBL] [Abstract][Full Text] [Related]
31. The anticancer activity of chloroquine-gold nanoparticles against MCF-7 breast cancer cells.
Joshi P; Chakraborti S; Ramirez-Vick JE; Ansari ZA; Shanker V; Chakrabarti P; Singh SP
Colloids Surf B Biointerfaces; 2012 Jun; 95():195-200. PubMed ID: 22445746
[TBL] [Abstract][Full Text] [Related]
32. A novel aminopeptidase N inhibitor developed by virtual screening approach.
Feng J; Jin K; Zhu H; Zhang X; Zhang L; Liu J; Xu W
Bioorg Med Chem Lett; 2012 Sep; 22(18):5863-9. PubMed ID: 22901392
[TBL] [Abstract][Full Text] [Related]
33. Target fishing and docking studies of the novel derivatives of aryl-aminopyridines with potential anticancer activity.
Erić S; Ke S; Barata T; Solmajer T; Antić Stanković J; Juranić Z; Savić V; Zloh M
Bioorg Med Chem; 2012 Sep; 20(17):5220-8. PubMed ID: 22841617
[TBL] [Abstract][Full Text] [Related]
34. Growth inhibition and mechanism of action of p-dodecylaminophenol against refractory human pancreatic cancer and cholangiocarcinoma.
Imai M; Takahashi N
Bioorg Med Chem; 2012 Apr; 20(8):2520-6. PubMed ID: 22440084
[TBL] [Abstract][Full Text] [Related]
35. Stereospecific antitumor activity of radicicol oxime derivatives.
Soga S; Sharma SV; Shiotsu Y; Shimizu M; Tahara H; Yamaguchi K; Ikuina Y; Murakata C; Tamaoki T; Kurebayashi J; Schulte TW; Neckers LM; Akinaga S
Cancer Chemother Pharmacol; 2001 Dec; 48(6):435-45. PubMed ID: 11800023
[TBL] [Abstract][Full Text] [Related]
36. Autocatalytic phosphorylation of CDK2 at the activating Thr160.
Abbas T; Jha S; Sherman NE; Dutta A
Cell Cycle; 2007 Apr; 6(7):843-52. PubMed ID: 17361108
[TBL] [Abstract][Full Text] [Related]
37. Cis-enone resorcylic acid lactones (RALs) as irreversible protein kinase inhibitors.
Wei L; Wu J; Li G; Shi N
Curr Pharm Des; 2012; 18(9):1186-98. PubMed ID: 22316158
[TBL] [Abstract][Full Text] [Related]
38. Adapalene inhibits the activity of cyclin-dependent kinase 2 in colorectal carcinoma.
Shi XN; Li H; Yao H; Liu X; Li L; Leung KS; Kung HF; Lin MC
Mol Med Rep; 2015 Nov; 12(5):6501-8. PubMed ID: 26398439
[TBL] [Abstract][Full Text] [Related]
39. Natural resorcylic acid lactones: A chemical biology approach for anticancer activity.
Kuttikrishnan S; Prabhu KS; Al Sharie AH; Al Zu'bi YO; Alali FQ; Oberlies NH; Ahmad A; El-Elimat T; Uddin S
Drug Discov Today; 2022 Feb; 27(2):547-557. PubMed ID: 34655796
[TBL] [Abstract][Full Text] [Related]
40. Direct antiproliferative effect of nonsteroidal 17β-hydroxysteroid dehydrogenase type 1 inhibitors in vitro.
Berényi Á; Frotscher M; Marchais-Oberwinkler S; Hartmann RW; Minorics R; Ocsovszki I; Falkay G; Zupkó I
J Enzyme Inhib Med Chem; 2013 Aug; 28(4):695-703. PubMed ID: 22471733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]